1. Home
  2. MYRG vs NUVB Comparison

MYRG vs NUVB Comparison

Compare MYRG & NUVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MYRG
  • NUVB
  • Stock Information
  • Founded
  • MYRG 1891
  • NUVB 2018
  • Country
  • MYRG United States
  • NUVB United States
  • Employees
  • MYRG N/A
  • NUVB N/A
  • Industry
  • MYRG Water Sewer Pipeline Comm & Power Line Construction
  • NUVB Biotechnology: Pharmaceutical Preparations
  • Sector
  • MYRG Industrials
  • NUVB Health Care
  • Exchange
  • MYRG Nasdaq
  • NUVB Nasdaq
  • Market Cap
  • MYRG 2.9B
  • NUVB 2.4B
  • IPO Year
  • MYRG N/A
  • NUVB N/A
  • Fundamental
  • Price
  • MYRG $224.50
  • NUVB $7.97
  • Analyst Decision
  • MYRG Buy
  • NUVB Strong Buy
  • Analyst Count
  • MYRG 7
  • NUVB 8
  • Target Price
  • MYRG $200.67
  • NUVB $9.63
  • AVG Volume (30 Days)
  • MYRG 254.1K
  • NUVB 11.4M
  • Earning Date
  • MYRG 10-29-2025
  • NUVB 11-03-2025
  • Dividend Yield
  • MYRG N/A
  • NUVB N/A
  • EPS Growth
  • MYRG 169.25
  • NUVB N/A
  • EPS
  • MYRG 6.17
  • NUVB N/A
  • Revenue
  • MYRG $3,514,140,000.00
  • NUVB $26,748,000.00
  • Revenue This Year
  • MYRG $7.90
  • NUVB $283.17
  • Revenue Next Year
  • MYRG $8.46
  • NUVB $340.98
  • P/E Ratio
  • MYRG $35.92
  • NUVB N/A
  • Revenue Growth
  • MYRG N/A
  • NUVB 1137.19
  • 52 Week Low
  • MYRG $97.72
  • NUVB $1.54
  • 52 Week High
  • MYRG $241.13
  • NUVB $8.24
  • Technical
  • Relative Strength Index (RSI)
  • MYRG 55.05
  • NUVB 80.85
  • Support Level
  • MYRG $199.31
  • NUVB $6.51
  • Resistance Level
  • MYRG $229.12
  • NUVB $7.50
  • Average True Range (ATR)
  • MYRG 11.94
  • NUVB 0.62
  • MACD
  • MYRG -1.88
  • NUVB 0.27
  • Stochastic Oscillator
  • MYRG 62.16
  • NUVB 92.48

About MYRG MYR Group Inc.

MYR Group Inc is a U.S.-based holding company that provides specialty electrical construction services through its subsidiaries. The company operates through two segments. The transmission and distribution segment provides designing, engineering, procurement, construction, upgrade, maintenance, and repair services on transmission and distribution networks and substation facilities. The commercial and industrial segment provides services such as the design, installation, maintenance, and repair of commercial and industrial wiring, installation of traffic networks, and the installation of bridges. MYR Group generates the majority of its sales from the United States and Canada.

About NUVB Nuvation Bio Inc.

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor specifically designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes differentiated, novel oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in their different stages of development. The company generates revenue through out-licensing collaborative agreements with its customers located in China and Japan.

Share on Social Networks: